- Contract Packaging
- Leaders in Packaging
Article | April 30, 2006
Packaging and prescription drug plans
A recent Packworld.com survey asked if senior drug plans will have an impact on packaging. Here’s a sampling of responses…
• “Seniors will be demanding lower-cost higher-quality products” said a respondent with a maker of pharmaceuticals and medical devices. “They will go with what is the most cost-efficient since they are on a fixed budget.”
• “The impact will be the requirement to make pharmaceuticals more in line with commodity goods instead of the super-high-profit business it was. This will require the implementation of processes such as Six Sigma for cost reduction and process improvement or just-in-time manufacturing and automation.”
• Besides cost issues a respondent with a maker of solid-dose and liquid pharmaceuticals said “The big challenge is helping seniors self-manage their drug dosing given the increasing complexity of their regimens and their declining ability to handle complex tasks requiring memory and organization skills.”
• “Expect more diversity in how products are packaged. [That will create] additional confusion for consumers [with] the potential for medication errors and product confusion” said the employee of a firm that makes all types of pharmaceuticals.
• Another respondent with a firm making pharmaceuticals biopharmaceuticals and lyophylized products predicted an “increase in blister packs dosage-guided packages and expanded-content labeling.”
• And how about this response from a professional with a company that makes a wide variety of pharmaceuticals nutraceuticals and medical devices: “Watch for direct-to-consumer in the next three to five years taking the place of traditional pharmacy operations.” [HCP]
Related Sponsored Content
E-Book Special Report
Total Cost of Ownership
Sign up to receive timely updates from our editors and download this E-Book Special Report to learn how to calculate the true Total Cost of Ownership (TCO) of your packaging machinery.